ViruxNasal® og ViruxOral® are two synergistic medical devices that create a temporary barrier when administered to the nose and mouth. The goal is to reduce viral load in the upper respiratory tract, and thus, help the immune system defend against infection. In Laboratory tests the product has been confirmed to destroy the SARS-CoV-2 virus which causes the Covid-19 disease.
Viruxal® creates a temporary protective barrier when administered to the nose and mouth. The protective barrier helps reduce viral load by preventing illness-causing airborne microbes from adhering to mucosal tissue surfaces.
Break & Destroy
Viruxal® contains fatty acids that break up the lipid envelope of viruses through their polar and non-polar nature and in that way, destroy them. Viruxal® has been confirmed to destroy >99,97% of SARS-CoV-2, which causes COVID-19, in a laboratory setting at Utah State University.
Lyf og Heilsa
Distributor inqueries welcome.